Predictors of Underutilization of Medical Therapy in Patients Undergoing Endovascular Revascularization for

S Elissa Altin1, Yulanka S Castro-Dominguez2, Kevin F Kennedy3

  • 1Division of Cardiology, Yale University, New Haven, Connecticut, USA; West Haven VA Medical Center, West Haven, Connecticut, USA.

Insights

Less than half of patients receive guideline-directed medical therapy (GDMT) after lower extremity (LE) peripheral vascular intervention (PVI). Women and high-risk patients were less likely to receive GDMT, highlighting a need for improved prescription practices.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Surgery
  • Health Outcomes Research

Background:

  • Guideline-directed medical therapy (GDMT) is crucial for managing patients with peripheral artery disease (PAD).
  • Contemporary prescription rates of GDMT following lower extremity (LE) endovascular peripheral vascular intervention (PVI) are not well-established.
  • Understanding factors influencing GDMT prescription is vital for optimizing patient care.

Purpose of the Study:

  • To investigate the discharge prescription rates of GDMT after LE PVI.
  • To identify predictors of GDMT prescription in patients undergoing LE PVI for symptomatic PAD.

Main Methods:

  • Analysis of data from the 2014-2018 Vascular Study Group of New England Vascular Quality Initiative.
  • Inclusion of 12,316 patients undergoing LE PVI for symptomatic PAD.
  • Multivariate logistic regression to identify independent predictors of discharge GDMT prescription.

Main Results:

  • Only 47.4% of patients were discharged on GDMT (antiplatelet agent, statin, ACE inhibitor/ARB).
  • Antiplatelet agents were most common (95.2%), followed by statins (83.5%) and ACE inhibitors/ARBs (55.8%).
  • Female sex, older age, end-stage renal disease, chronic limb-threatening ischemia, and congestive heart failure were negative predictors; hypertension, diabetes, CAD, and prior interventions were positive predictors.

Conclusions:

  • Fewer than half of patients undergoing LE PVI receive appropriate GDMT.
  • While traditional risk factors predict GDMT use, women and high-risk patients are less likely to receive it.
  • Educational interventions are needed to address treatment gaps and improve GDMT prescription rates.
Abstract

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
119
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
142
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
173
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
160
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
158
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
149